Visiongain has launched a new pharma report ‘’Nuclear Medicine Market Report 2020-2030’’ by type {Diagnostic Nuclear Medicine (PET Radiopharmaceuticals, SPECT Radiopharmaceuticals), Therapeutic Nuclear Medicine (Alpha Emitters, Beta Emitters, Brachytherapy Isotopes)}, Application {Diagnostic Applications (PET Applications, SPECT Applications), Therapeutic Applications (Bone Metastasis, Endocrine Tumors, Lymphoma, Thyroid, Other Therapeutic Applications)}, and Geography.
To read more please visit:
Source: VisionGain